| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |